Drug maker Savient Pharmaceuticals Inc. said Monday it has filed a patent lawsuit against Novartis AG subsidiary Sandoz Pharmaceuticals and privately held Upsher-Smith Laboratories Inc. Savient said its suit alleges infringement of its patents on methods of using Oxandrin, an oral anabolic agent designed to help patients gain weight after weight loss from surgery, infection or severe trauma. The company said its suit was filed in the U.S. District Court for New Jersey. Savient said its lawsuit follows a decision by the Food and Drug Administration late Friday to deny two citizens petitions it filed, and "reliable information" the company has received that the FDA has approved Abbreviated New Drug Applications from both Sandoz and Upsher-Smith.

Posted by GEN-ERIC at 12:04:33 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/946

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)